NCT07206472View on ClinicalTrials.gov

A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia

Not yet recruitingOBSERVATIONAL
Enrollment

2,560

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

September 1, 2028

Study Completion Date

March 1, 2029

Conditions
Primary HypercholesterolaemiaMixed Dyslipidemia
Interventions
DRUG

Combination of bempedoic acid and ezetimibe

No drug was administered in this observational study.

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY

NCT07206472 - A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia | Biotech Hunter | Biotech Hunter